OXFORD, BRISTOL, EDINBURGH, UK – 15 December 2023 – Leading computational biology company PrecisionLife®, which is driving precision medicine in complex chronic diseases, the ME/CFS charity Action for M.E., and the MRC Human Genetics Unit at the Institute of Genetics and Cancer, University of Edinburgh have been awarded a £622,000 grant by Innovate UK's Advancing Precision Medicine programme to improve diagnosis and treatment for the millions of people affected by ME/CFS and long Covid.
ME/CFS and long Covid are debilitating conditions profoundly affecting the quality of life of over two…
We are excited to reach out to you, CEBR (Council of European BioRegion), network of health clusters from which your cluster is an active member, invites you to participate in a pivotal survey aimed at advancing the interests and growth of European health sector SMEs through internationalization.
About the Survey:
CEBR is at the forefront of an alliance of bio clusters dedicated to strengthening the health sector's internationalization. This survey is a cornerstone in our collective efforts to understand the unique challenges and requirements of SMEs in this dynamic…
As 2023 concludes, Biocair, an established global leader in life sciences logistics, proudly announces a year of remarkable achievements. With significant strides in sustainability, strategic partnerships and global expansion, Biocair affirms its commitment to being the specialist in temperature-controlled logistics for the life sciences industry.
Sustainability at the forefront:
In a landmark move towards its goal of becoming a net-zero business by 2040, Biocair introduced 100% electric vans to its Cambridge fleet in April. This step reflects Biocair's dedication to sustainable…
Cancer Research UK has appointed industry veteran Dr Lars Erwig as the new director for its Centre for Drug Development, the world's only charity-funded drug development facility.
With Cancer Research UK’s aim to beat cancer, the centre has a critical role to play in partnering with others to ensure that pre-clinical and early-phase clinical projects with the highest potential for patient benefit are prioritised and rapidly advanced.
In his new role, Dr Erwig will be responsible for shaping an exciting and cutting-edge portfolio of first-in-human trials for the charity, working closely…
Specialist Intellectual Property law firm Reddie & Grose is delighted to introduce its brand-new podcast series, ‘Talk IP with R&G’.
Hosted by experts from across the firm, the regular podcast is a go-to resource on how businesses can make the most of their intellectual property.
The first two episodes focus on using the Patent Box to lower your corporate tax bills; and on telling you everything you need to know about the Unified Patent Court, the most significant change to the European patent system in 50 years.
Subscribe and listen on Apple Podcasts or Spotify.
Pioneer Group, a company combining laboratory development and operation with venture building, is continuing its collaboration with Innovate UK by bringing its venture development ‘Launch Programme’ to the Exploit stage of Innovate UK’s ICURe programme.
The Launch Programme welcomes invited life science founders from the ICURe Programme, as well as the Pioneer Group ecosystem, to provide support in accelerating their development from lab to market adoption.
The ICURe programme is designed to help researchers explore the commercial application and potential of UK research. Building confidence…
London, UK; December 11, 2023 — AviadoBio, a pioneering gene therapy company dedicated to developing and delivering potentially transformative medicines for neurodegenerative disorders, today announced the appointment of John Isaac, Ph.D., as Chief Scientific Officer. Previous interim Chief Scientific Officer and AviadoBio co-founder, Professor Chris Shaw, will remain an active member of the leadership team and resume his prior roles as Chief Scientific and Clinical Advisor and Board Observer.
“John has made a significant impact on our research and development team since joining…
Download the My Green Lab 2023 Carbon Impact of Biotech & Pharma report now!
In an informative new blog post - AMSBIO reflects on a selection of the groundbreaking life science and biomedical research undertaken by its customers during 2023. From deciphering the intricacies of cancer progression mechanisms to revolutionising wound care, AMSBIO is delighted to have played a supporting role in these scientific endeavours.
Discover an exciting collaboration led by Dr. Ashley M. Laughney from Weill Cornell Medicine and Dr. Samuel F. Bakhoum from Memorial Sloan Kettering Cancer Center where they investigated the intricate mechanisms through which chromosomal instability…
MHA is excited to announce the appointment of Chris Liu as Partner who will lead our successful Transfer Pricing Team in the International Marketplace.
Chris will lead MHA’s Transfer Pricing Team nationally and globally through the Baker Tilly International network. Chris’s extensive experience includes management of transfer pricing projects for numerous multinational groups in the UK and across Europe and he has deep industry expertise in TMT, Financial Services, Real Estate, Life Sciences, Manufacturing, Infrastructure, Energy and Natural Resources. Chris is a native Mandarin and Cantonese…